Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
